<img src='https://npr.brightspotcdn.com/dims3/default/strip/false/crop/5811×3874+0+0/resize/5811×3874!/?url=httppercent3Apercent2Fpercent2Fnpr-brightspot.s3.amazonaws.compercent2Fbcpercent2Fdepercent2F52a045a443cca25dc1dad309cd64percent2Fap24205636899403.jpg' alt='A pharmacist holds a vial of lenacapavir, on the Desmond Tutu Well being Basis's Masiphumelele Analysis Web site, in Cape City, South Africa. The drug's improvement has been heralded because the 2024 Breakthrough of the Yr by the journal Science, which described it as representing “a pivotal step towards diminishing HIV/AIDS as a worldwide well being disaster.”‘/>
That is the title that Science journal is bestowing upon the medicine referred to as lenacapavir — a twice yearly injectable that forestalls an infection by the HIV virus.
(Picture credit score: Nardus Engelbrecht)
